Hepatoprotective effects of Portulaca oleracea extract against CCl4-induced damage in rats

Pharmaceutical Biology

Volumn 53, Issue 7, 2015, Pages 1042-1051

  Eidi, Akram ^a   Mortazavi, Pejman ^b   Moghadam, Jalal Zarringhalam ^c   Mardani, Parisa Mousavi ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Carbon tetrachloride; Detoxification; Liver; Purslane

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; PORTULACA OLERACEA EXTRACT; SUPEROXIDE DISMUTASE; CARBON TETRACHLORIDE; PLANT EXTRACT; PROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMICAL COMPOSITION; BLOOD ANALYSIS; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; HISTOPATHOLOGY; LIVER INJURY; LIVER PROTECTION; LIVER TOXICITY; LIVER WEIGHT; MALE; NONHUMAN; PHYTOCHEMISTRY; RAT; TISSUE CHARACTERIZATION; ANIMAL; DOSE RESPONSE; DRUG-INDUCED LIVER INJURY; ISOLATION AND PURIFICATION; METABOLISM; PATHOLOGY; PLANT STRUCTURES; PORTULACA; WISTAR RAT;

PORTULACA OLERACEA; PORTULACACEAE; RATTUS; RATTUS NORVEGICUS;

ANIMALS; CARBON TETRACHLORIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-INDUCED LIVER INJURY; MALE; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS; PORTULACA; PROTECTIVE AGENTS; RATS; RATS, WISTAR;

EID: 84930800583     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2014.957783     Document Type: Article

References (62)

1. Awad NE. (1994). Lipid content and antimicrobial activity of phenolic constituents of cultivated Portulaca oleracea L. Bull Fac Pharm Cairo Univ 32:137-42.
2. Boulos L, El-Hadidi MN. (1984). The Weed Flora of Egypt. Cairo, Egypt: The American University in Cairo Press.
3. Brautbar N, Williams J. (2002). Industrial solvents and liver toxicity: Risk assessment, risk factors and mechanisms. Int J Hyg Environ Health 205:479-91.
4. Brent JA, Rumack BH. (1993). Role of free radicals in toxic hepatic injury. Clin Toxicol 31:173-96.
5. Bulle F, Mavier P, Zafrani ES, et al. (1990). Mechanism of gammaglutamyl transpeptidase release in serum during intrahepatic and extrahepatic cholestasis in the rat: A histochemical, biochemical and molecular approach. Hepatology 11:545-50.
6. Caballero-Salazar S, Riveron-Negrete L, Ordaz-Tellez MG, et al. (2002). Evaluation of the antimutagenic activity of different vegetable extracts using an in vitro screening test. Proc West Pharmacol Soc 45:101-3.
7. Cai Y, Luo Q, Sun M, Corke H. (2004). Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer. Life Sci 74:2157-84.
8. Chan K, Islam MW, Kamil M, et al. (2000). The analgesic and antiinflammatory effects of Portulaca oleracea L. subsp. sativa (Haw.) Celak. J Ethnopharmacol 73:445-51.
9. Cheng-Jie C, Wan-Yin W, Xiao-Li W, et al. (2009). Anti-hypoxic activity of the ethanol extract from Portulaca oleracea in mice. J Ethnopharmacol 124:246-50.
10. Dhiman A, Nanda A, Akmad S. (2012). A recent update in research on the antihepatotoxic potential of medicinal plants. J Chin Integr Med 10:117-27.
11. Dkhil MA, Abdel Moniem AE, Al-Quraishy S, Saleh RA. (2011). Antioxidant effect of purslane (Portulaca oleracea) and its mechanism of action. J Med Plants Res 5:1589-63.
12. Domenicali M, Caraceni P, Giannone F, et al. (2009). A novel model of CCl4-induced cirrhosis with ascites in the mouse. J Hepatol 51: 991-9.
13. Duh PD, Lin SL, Wu SC. (2011). Hepatoprotection of Graptopetalum paraguayense E. Walther on CCl4-induced liver damage and inflammation. J Ethnopharmacol 134:379-85.
14. El-Sayed M-IK. (2011). Effects of Portulaca oleracea L. seeds in treatment of type-2 diabetes mellitus patients as adjunctive and alternative therapy. J Ethnopharmacol 137:643-51.
15. Finar IL. (2003). Organic Chemistry. Stereochemistry and the Chemistry of Natural Products, vol. 2, 5th ed. Delhi: Pearson Education, 769-71.
16. French SW, Miyamoto K, Ohta Y, Geoffrion Y. (2000). Pathogenesis of experimental alcoholic liver disease in the rat. Methods Achiev Exp Pathol 13:181-207.
17. Grattagliano I, Bonfrate L, Catia VD, et al. (2009). Biochemical mechanisms in drug-induced liver injury. World J Gastroenterol 15: 4865-76.
18. Gray P. (1958). Handbook of Basic Microtechnique. 3rd ed. New York: McGraw-Hill, 45-85.
19. Halliwell B, Gutteridge JMC. (1990). Role of free radicals and catalytic metal irons in human disease: An overview. Methods Enzymol 186: 59-85.
20. Hongxing Z, Nancai Y, Guofu H, et al. (2007). Neuroprotective effects of purslane herb aqueous extracts against D-galactose induced neurotoxicity. Chem-Biol Interact 170:145-52.
21. Ikejima K, Enomoto N, Iimuro Y, et al. (1998). Estrogen increases sensitivity of hepatic Kupffer cells to endotoxin. Am J Physiol 274: G669-76.
22. Kaplan MM. (1986). Serum alkaline phosphatase-another piece is added to the puzzle. Hepatology 6:526-8.
23. Kucera O, Cervinkova Z, Lotkova H, et al. (2006). Protective effect of S-adenosylmethionine against galactosamine-induced injury of rat hepatocytes in primary culture. Physiol Res 55:551-60.
24. Kuo DH, Kang WH, Shieh PC, et al. (2010). Protective effect of Pracparatum mungo extract on carbon tetrachloride-induced hepatotoxicity in rats. Food Chem 123:1007-12.
25. Ledda-Columbano GM, Coni P, Curto M, et al. (1991). Induction of two different modes of cell death, apoptosis and necrosis, in rat liver after a single dose of thioacetamide. Am J Pathol 139:1099-109.
26. Lee CP, Shih PH, Hsu CL, Yen GC. (2007). Hepatoprotection of tea seed oil (Camellia oleifera Abel.) against CCl4-induced oxidative damage in rats. Food Chem Toxicol 45:888-95.
27. Liu LX, Howe P, Zhou YF, et al. (2000). Fatty acids and beta-carotene in Australian purslane (Portulaca oleracea) varieties. J Chromatogr A 893:207-13.
28. Mukherjee PK. (2002). Quality Control of Herbal Drugs, 1st ed. New Delhi: Business Horizons Pharmaceutical Publication, 531.
29. Naik SR, Panda VS. (2008). Hepatoprotective effect of Ginkgoselect phytosome in rifampicin induced liver injury in rats: Evidence of antioxidant activity. Fitoterapia 79:439-45.
30. Navarro VJ, Senior JR. (2006). Drug related hepatotoxicity. N Engl J Med 354:731-9.
31. Neichi T, Koshihara Y, Murota S. (1983). Inhibitory effect of esculetin on 5-lipoxygenase and leukotriene biosynthesis. Biochim Biophys Acta 753:130-2.
32. Nwozo SO, Osunmadewa DA, Oyinloye BE. (2014). Anti-fatty liver effects of oils from Zingiber officinale and Curcuma longa on ethanolinduced fatty liver in rats. J Integr Med 12:59-65.
33. Ohta Y, Kongo-Nishimura M, Matsura T, et al. (2004). Melatonin prevents disruption of hepatic reactive oxygen species metabolism in rats treated with carbon tetrachloride. J Pineal Res 36:10-17.
34. Oliveira I, Valentaõ P, Lopes R, et al. (2009). Phytochemical characterization and radical scavenging activity of Portulaca oleraceae L. leaves and stems. Microchem J 92:129-34.
35. Parekh J, Karathia N, Chanda S. (2006). Antibacterial activity of Bauhinia variegata. J Biomed Res 9:53-6.
36. Parry O, Marks JA, Okwuasaba FK. (1993). The skeletal muscle relaxant action of Portulaca oleracea: Role of potassium ions. J Ethnopharmacol 40:187-94.
37. Parry O, Okwuasaba F, Ejike C. (1987). Skeletal muscle relaxant action of an aqueous extract of Portulaca oleracea in the rat. J Ethnopharmacol 19:247-53.
38. Perez-Alvarez V, Bobadilla-Lugo RA, Murel P, et al. (1993). Effects of leukotriene synthesis inhibition on acute liver damage induced by carbon tetrachloride. Pharmacology 47:330-6.
39. Quan J, Yin X, Xu H. (2011). Boschniakia rossica prevents the carbon tetrachloride-induced hepatotoxicity in rat. Exp Toxicol Pathol 63: 53-9.
40. Rando G, Wahli W. (2011). Sex differences in nuclear receptor-regulated liver metabolic pathways. Biochim Biophys Acta 1812:964-73.
41. Rashed AN, Afifi FU, Disi AM. (2003). Simple evaluation of the wound healing activity of a crude extract of Portulaca oleracea L. (growing in Jordan) in Mus musculus JVI-1.J Ethnopharmacol 88: 131-6.
42. Recknagel RO, Glende Jr EA, Britton RS. (1991). Free radical damage and lipid peroxidation. In: Meeks RG, ed. Hepatotoxicology. Florida: CRC Press, 401-36.
43. Recknagel RO, Glende Jr EA, Dolak JA, Waller RL. (1989). Mechanisms of carbon tetrachloride toxicity. Pharmacol Ther 43: 139-54.
44. Ree KR, Spector WG. (1961). Reversible nature of liver cell damage due to carbon tetrachloride as demonstrated by the use of phenergan. Nature 190:821-2.
45. Reitman S, Frankel S. (1957). A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminase. Am J Pathol 28:57-60.
46. Rousar T, Kucera O, Krivakova P, et al. (2009). Evaluation of oxidative status in acetaminophen treated rat hepatocytes in culture. Physiol Res 58:239-46.
47. Sakai N, Inada K, Okamoto M, et al. (1996). Portuloside A, a monoterpene glucoside from Portulaca oleracea. Phytochemistry 42:1625-8.
48. Shahjahan M, Sabitha KE, Jainu M, Devi CSS. (2004). Effect of Solanum trilobatum against carbon tetrachloride induced hepatic damage in albino rats. Indian J Med Res 120:194-8.
49. Sharma V, Janmeda P, Paliwal R, Sharma S. (2012). Antihepatotoxic activity of Euphorbia neriifolia extract against N-nitrosodiethylamineinduced hepatocarcinogenesis in mice. J Chin Integr Med 10: 1303-9.
50. Sheweita SA, El-Gabar MA, Bastawy M. (2001). Carbon tetrachlorideinduced changes in the activity of phase II drug-metabolizing enzyme in the liver of male rats: Role of antioxidants. Toxicology 165:217-24.
51. Siriamornpun S, Suttajit M. (2010). Microchemical components and antioxidant activity of different morphological parts of Thai wild purslane (Portulaca oleracea). Weed Sci 58:182-8.
52. Song HY, Zhang L, Pan JL, et al. (2013). Bioactivity of five components of Chinese herbal formula Jiangzhi granules against hepatocellular steatosis. J Integr Med 11:262-8.
53. Sun Y, Oberley LW, Li Y. (1988). Simple method for clinical assay of superoxide dismutase. Clin Chem 34:497-500.
54. Taniguchi M, Takeuchi T, Nakatsuka R, et al. (2004). Molecular process in acute liver injury and regeneration induced by carbon tetrachloride. Life Sci 75:1539-49.
55. Vogel HG. (2002). Carbon tetrachloride induced liver fibrosis in rats. In: Vogel HG, Vogel WH, eds. Drug Discovery and Evaluation, Pharmacological Assays, 2nd ed. Berlin: Springer-Verlag, p. 942.
56. Vuda M, D'Souza R, Upadhya S, et al. (2012). Hepatoprotective and antioxidant activity of aqueous extract of Hybanthus enneaspermus against CCl4-induced liver injury in rats. Exp Toxicol Pathol 64: 855-9.
57. Wang CQ, Yang GQ. (2010). Betacyanins from Portulaca oleracea L. ameliorate cognition deficits and attenuate oxidative damage induced by D-galactose in the brains of senescent mice. Phytomedicine 17: 527-32.
58. Weber LW, Boll M, Stampfl A. (2003). Hepatotoxicity and mechanism of action of haloalkanes: Carbon tetrachloride as a toxicological model. Crit Rev Toxicol 33:105-36.
59. Wills PJ, Asha VV. (2006). Protective effect of Lygodium flexuosum (L.) Sw. extract against carbon tetrachloride-induced acute liver injury in rats. J Ethnopharmacol 108:320-6.
60. Yang L, Wang CZ, Ye JZ, Li HT. (2011). Hepatoprotective effects of polyprenols from Ginkgo biloba L. leaves on CCl4-induced hepatotoxicity in rats. Fitoterapia 82:834-40.
61. YoonJW, HamSS, JunHS. (1999).Portulaca oleracea and tumorcell growth. US Patent. 5869060. Washington DC: Patent and Trademark Office.
62. Zhang XJ, Ji YB, Qu ZY, et al. (2002). Experimental studies on antibiotic functions of Portulaca oleracea L. in vitro. Chin J Microbiol Immunol 14:277-80.